[Clinical experience with different methods of treating herpes corneae (author's transl)].
The modes of action of IDU and TFT were compared in tests employing them both as a monotherapy and in combination with iodine debridement in 60 patients suffering from superficial herpetic keratitis. The combination therapy was used for patients showing only dendritic stains in the corneal epithelium, while the monotherapy was used for patients who had additional lesions in the region of Bowman's membrane. Both with the monotherapies and the combination therapies the average duration of healing was shorter with TFT.
D003646:Debridement / Q000379:methods; D004359:Drug Therapy, Combination; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007455:Iodine / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D013936:Thymidine / Q000031:analogs & derivatives*; D014271:Trifluridine / Q000627:therapeutic use*
D007455:Iodine; D007065:Idoxuridine; D014271:Trifluridine; D013936:Thymidine
Klinische Erfahrungen über die Therapie des Herpes corneae mit verschiedenen Behandlungsmethoden.